Adrenoleukodystrophy
Neurology·MeSH: Peroxisomal Disorders
2 drugs in development·2 companies·2 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| SKYSONA | bluebird bio, Inc. (BLUE) |
Phase 1(1)
| Drug | Company |
|---|---|
| VK0214 | Viking Therapeutics, Inc. (VKTX) |
Compare drugs
Frequently asked questions
How many drugs are in development for Adrenoleukodystrophy?
BioSniper tracks 2 drugs in development for Adrenoleukodystrophy across 2 companies.
How many clinical trials target Adrenoleukodystrophy?
There are 2 clinical trials targeting Adrenoleukodystrophy tracked by BioSniper.
Deep-dive into Adrenoleukodystrophy
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis